Patent ID: 8435998

Claim:
A crystalline form IV of posaconazole having at least one of an X-ray powder diffraction pattern comprising peaks at 2-theta angles of 3.2°±0.2°, 6.6°±0.2°, 10.9°±0.2°, 16.9°±0.2°, 18.4°±0.2° and 25.1°±0.2° or an attenuated total reflectance infrared spectrum comprising absorption bands at wavenumbers of 3647 cm −1 ±2 cm −1 , 3472 cm −1 ±2 cm −1 , 2867 cm −1 ±2 cm −1 , 1687 cm −1 ±2 cm −1 , 1512 cm −1 ±2 cm −1 , 1230 cm −1 ±2 cm −1 , 1136 cm −1 ±2 cm −1 , 916 cm −1 ±2 cm −1 , 853 cm −1 ±2 cm −1 , 819 cm −1 ±2 cm −1 and 681 cm −1 ±2 cm −1 .